Archimedes Laboratories, Inc. – Trademark Portfolio
Entity Type: 03
Archimedes Laboratories, Inc. has 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include VIRUN. The portfolio includes 1 registered trademark. Filings span 4 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 5 (Pharmaceuticals). This trademark owner is based in Walnut, CA.
21118 Commerce Pointe Dr.
Walnut, CA 91789
Showing of trademarks Trademarks
Trademark Classifications
Archimedes Laboratories, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Archimedes Laboratories, Inc. have?
Archimedes Laboratories, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned.
What trademark classes does Archimedes Laboratories, Inc. file in?
Archimedes Laboratories, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Archimedes Laboratories, Inc.'s most well-known trademarks?
Archimedes Laboratories, Inc.'s registered trademark portfolio includes well-known marks such as VIRUN. These are among 1 currently registered trademark in the portfolio.
What is Archimedes Laboratories, Inc.'s trademark registration success rate?
Archimedes Laboratories, Inc. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.